Detalles de la búsqueda
1.
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Prostate
; 82(7): 858-866, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286730
2.
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Cancer
; 127(16): 2954-2965, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951180
3.
Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
Genes Chromosomes Cancer
; 59(4): 225-239, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31705765
4.
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.
Prostate
; 79(15): 1752-1761, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31497882
5.
Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer.
Prostate
; 79(10): 1106-1116, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31045266
6.
EGFR and C/EBP-ß oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-ß isoform.
FASEB J
; 30(12): 4098-4108, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27572958
7.
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
Prostate Cancer Prostatic Dis
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388778
8.
Matrix metalloproteinase-1 expression enhances tumorigenicity as well as tumor-related angiogenesis and is inversely associated with TIMP-4 expression in a model of glioblastoma.
J Neurooncol
; 106(3): 461-71, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21858729
9.
Structure of eEF3 and the mechanism of transfer RNA release from the E-site.
Nature
; 443(7112): 663-8, 2006 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-16929303
10.
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).
Prostate Cancer Prostatic Dis
; 25(1): 58-64, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35273377
11.
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Prostate Cancer Prostatic Dis
; 25(4): 762-769, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292724
12.
Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer.
Mol Cancer Res
; 19(6): 1040-1050, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33771885
13.
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 109(5): 1271-1278, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33259932
14.
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer.
Biomark Res
; 9(1): 14, 2021 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602330
15.
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.
Eur Urol Oncol
; 4(6): 948-954, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32063492
16.
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.
Clin Cancer Res
; 27(14): 4077-4088, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820782
17.
Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer.
Urol Oncol
; 38(3): 79.e15-79.e22, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31522863
18.
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 42020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33154984
19.
Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia.
Clin Cancer Res
; 14(22): 7564-8, 2008 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19010875
20.
Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients.
Prostate Cancer Prostatic Dis
; 22(4): 588-592, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30980027